More on Aldeyra Q2 results


Aldeyra Therapeutics (NASDAQ:ALDX) Q2 results: Revenue: $0; Operating Expenses: $1.6M; Operating Loss: ($1.6M) (-67.0%); Net Loss: ($5.3M) (-210.1%); Loss Per Share: ($1.56) (+71.5%); Quick Assets: $11.5M (+248.5%).

No guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs